Reckitt Benckiser Group PLC (RB.L)
July 30 Europe's main STOXX 600 index posted its worst session since a selloff in May on Tuesday after U.S. President Donald Trump ramped up his trade rhetoric against China, deepening wounds left by a batch of weak economic data and corporate earnings.
LONDON Reckitt Benckiser cut its full-year revenue target after reporting lower than expected sales in its last quarter under long-time chief executive Rakesh Kapoor, hurt by a surprise slowdown in demand for infant formula in China.
* Health unit posts surprise sales drop due to China slowdown
European shares slipped on Tuesday as grim forecasts from German giants Bayer and Lufthansa soured sentiment, while a battered pound helped London's blue-chip index outperform for a second day. | Video
July 30 A surge in oil major BP offset steep losses in consumer goods giant Reckitt Benckiser and energy utility Centrica and lifted London's FTSE 100 to a fresh 11-month high on Tuesday.
July 30 Britain's FTSE 100 index is expected to open 22 points higher at 7,709 on Tuesday, according to financial bookmakers, with futures up 0.24% ahead of the cash market open.
FRANKFURT Germany's Bayer signed a deal on Monday to sell its Dr. Scholl's footcare brand to U.S. private investment firm Yellow Wood Partners for $585 million, the second of two consumer care products it had put on the block.
* U.S. buyer Yellow Wood to create stand-alone company (Adds background on strategic overhaul, share price rout)
FRANKFURT, July 22 Bayer on Monday said it had agreed to sell its Dr. Scholl's footcare brand to Boston-based private investment firm Yellow Wood Partners for $585 million, the second of two consumer care products it had planned to divest.
Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment. | Video